Exchange: NASDAQ·Updated 04:10 PM EST

About COAG

About

Hemab Therapeutics Holdings, Inc. operates as a clinical-stage biotechnology company. It engages in developing therapies that reimagine the treatment of blood coagulation disorders to sustain life and human resilience. The company was founded in 2020 and is headquartered in Cambridge, MA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
72

Frequently Asked Questions

Advertisement|Remove ads.